UBS Initiates Coverage On 89bio with Buy Rating, Announces Price Target of $36
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Eliana Merle has initiated coverage on 89bio (NASDAQ:ETNB) with a Buy rating and a price target of $36.
August 28, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has initiated coverage on 89bio with a Buy rating and a price target of $36, which could positively impact the stock's performance.
Analyst ratings and price targets can significantly influence a stock's performance. A Buy rating from a reputable institution like UBS indicates a positive outlook for the stock. The price target of $36 also suggests a potential upside, which could attract investors and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100